Form 4 for IMUX IMMUNIC, INC.
Accepted 2022-05-16 00:00:00 ET · period of report 2022-05-12 · accession 0001193805-22-000800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-16 | 2022-05-12 | IMUX | Muehler Andreas | Chief Medical Off | P - Purchase | $5.10 | +3,500 | 298.0K | +1% | +$17.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-12 | P | A | 3,500 | $5.10 | 297,986 | D | — | — | (F1) Consists of 13,506 shares of common stock held directly by the Reporting Person and 284,480 shares of common stock held indirectly by Xanomed GmbH, an entity controlled by the Reporting Person. |